Sage Rhino Capital LLC Astrazeneca PLC Transaction History
Sage Rhino Capital LLC
- $411 Million
- Q1 2024
A detailed history of Sage Rhino Capital LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sage Rhino Capital LLC holds 11,628 shares of AZN stock, worth $891,518. This represents 0.19% of its overall portfolio holdings.
Number of Shares
11,628
Previous 11,382
2.16%
Holding current value
$891,518
Previous $766,000
2.74%
% of portfolio
0.19%
Previous 0.19%
Shares
20 transactions
Others Institutions Holding AZN
# of Institutions
1,250Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.7 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.29 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.32 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...